Oncogenesis

New Marker Shows Changes Created During Cervical Cancer

Published in Cancer Weekly, October 10th, 2000

An old protein may have a new use as a marker for cervical cancer, according to research scientists at the University of Illinois' College of Medicine.

The protein, which is characterized as being a member of the transforming growth factor (TGF) beta 1 receptor structure, is called endoglin. According to researchers reporting in the journal Obstetrics and Gynecology, endoglin might be an endothelial marker for new growth in cervical cancers.

Medical investigators obtained cervical cancer tumor samples from 31 women who had been previously diagnosed with stage 1B cervical cancer. Tumor size was less than 5 cm in the cancer patients.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-10-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry